Lilly announces departure of Anat Ashkenazi, chief financial officer

INDIANAPOLIS, June 5, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry. “On behalf of our board of directors, leadership team and…

Leave a Reply

Your email address will not be published. Required fields are marked *